These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17196505)

  • 41. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
    Federman DG
    Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
    [No Abstract]   [Full Text] [Related]  

  • 42. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
    Saraswat A; Kumar B
    Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
    [No Abstract]   [Full Text] [Related]  

  • 43. Chemoprevention of prostate cancer.
    Walsh PC
    N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
    [No Abstract]   [Full Text] [Related]  

  • 44. The influence of finasteride on the development of prostate cancer.
    Thompson IM; Goodman PJ; Tangen CM; Lucia MS; Miller GJ; Ford LG; Lieber MM; Cespedes RD; Atkins JN; Lippman SM; Carlin SM; Ryan A; Szczepanek CM; Crowley JJ; Coltman CA
    N Engl J Med; 2003 Jul; 349(3):215-24. PubMed ID: 12824459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Does the new pill to treat baldness really work?
    Mayo Clin Health Lett; 1998 May; 16(5):8. PubMed ID: 9581135
    [No Abstract]   [Full Text] [Related]  

  • 46. Finasteride and minoxidil for alopecia revisited.
    Med Lett Drugs Ther; 2005 Nov; 47(1222):95-6. PubMed ID: 16299452
    [No Abstract]   [Full Text] [Related]  

  • 47. A review of hormonal therapy for female pattern (androgenic) alopecia.
    Scheinfeld N
    Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Finasteride in the treatment of benign prostatic hyperplasia.
    Ekman P; Andersen JT; Wolf H
    Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Androgens and prostate cancer risk.
    Wirén S; Stattin P
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):601-13. PubMed ID: 18971121
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propecia and Rogaine Extra Strength for alopecia.
    Med Lett Drugs Ther; 1998 Feb; 40(1021):25-7. PubMed ID: 9505960
    [No Abstract]   [Full Text] [Related]  

  • 51. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD; Howlader N; Shaw PA; Ankerst DP; Penson DF; Goodman PJ; Thompson IM
    J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.
    Boychenko O; Bernstein RM; Schweiger ES
    Cutis; 2012 Aug; 90(2):73-6. PubMed ID: 22988650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-grade prostate cancer and finasteride.
    Lebdai S; Bigot P; Azzouzi AR
    BJU Int; 2010 Feb; 105(4):456-9. PubMed ID: 19930174
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct-to-consumer advertising. Finasteride for male pattern hair loss.
    Cassels A; Wright JM; Mintzes B; Jauca C
    Can Fam Physician; 2001 Sep; 47():1751-5. PubMed ID: 11570300
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial.
    Walsh PC
    J Urol; 1999 Jan; 161(1):350-1. PubMed ID: 10037436
    [No Abstract]   [Full Text] [Related]  

  • 57. Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite.
    Paik SH; Cho HH; Jeon HC; Jo SJ; Kwon OS
    Br J Dermatol; 2012 Jan; 166(1):221-2. PubMed ID: 21729028
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of hormone-related cancers: prostate cancer.
    Parnes HL; Thompson IM; Ford LG
    J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The evolution of the PCPT from clinical to molecular analyses.
    Hoque A
    Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
    [No Abstract]   [Full Text] [Related]  

  • 60. Finasteride-associated male infertility.
    Chiba K; Yamaguchi K; Li F; Ando M; Fujisawa M
    Fertil Steril; 2011 Apr; 95(5):1786.e9-11. PubMed ID: 21193189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.